Description: AngioDynamics shows how product mix shifts toward higher-margin Med Tech platforms are quietly reshaping earnings power across medtech stocks.

Description: Medtronic revealed that since Altaviva’s FDA approval in September 2025, 500 physicians have been trained to deploy the urinary incontinence implantable.

Description: ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable growth across MedTech.

Description: Medtronic will access anonymized brain data and co-develop a surgical system mapping neural activity in real time.

Description: Medtronic asserted that key markets it targets including PFA and renal denervation represent lucrative opportunities in the near future.

Description: SAN FRANCISCO, January 13, 2026--Zip Launches Enterprise Transformation Office, Tapping Former Fortune 500 CPOs to Guide Procurement Leaders Through AI-Era Change

Description: Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) ("Oramed") and Lifeward Ltd. (NASDAQ: LFWD) ("Lifeward") today announced the signing of binding agreements for a strategic transaction between Oramed, Lifeward and a certain accredited investor. The transaction includes the transfer to Lifeward of Oramed's proprietary Protein Oral Drug POD™ delivery technology and Oramed obtaining 49.9% beneficial ownership interest in Lifeward upon the satisfaction of certain terms and conditions. In addit

Description: JNJ's MedTech unit is gaining momentum from cardiovascular strength and new products, even as China pressure lingers into the next quarter.

Description: NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced a strategic partnership with Medtronic to advance neurosurgery, leveraging Precision’s brain–computer interface (BCI) technology and Medtronic’s Neuroscience portfolio. The companies will co-develop an integrated solution that combines Precision’s Layer 7™ cortical interface with the Medtronic StealthStation™ surgical navigation system. Today, neurosurgeons often rely on separate tools to v

Description: Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its MiniMed Go™ app. The MiniMed Go™ Smart Multiple Daily Injection (MDI) system seamlessly integrates the InPen™ smart insulin pen with the Instinct sensor made by Abbott — all connected through the MiniMed Go™ app. This powerful combination delivers real-time, personalized insights and actionable guidance, including:

Description: NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.

Description: The latest update on Medtronic edges its fair value estimate to US$111.05 per share, with a slightly lower discount rate of 8.78% and revenue growth now set at 5.73%, changes that reflect how recent Q2 results and product pipeline momentum are feeding into refreshed models. These tweaks are small but they align with a broader shift in how analysts are framing the story around Medtronic after a run of higher price targets and updated views on execution. Stay tuned to see how you can keep on...

Description: A real-world retrospective analysis published in Diabetes Care found that Medtronic’s MiniMed 780G insulin system users met American Diabetes Association time-in-range goals even on days when mealtime boluses were missed, particularly when SmartGuard technology was used with recommended optimal settings. The data, drawn from over 369,000 global CareLink users, highlights how optimized algorithm settings may help ease the daily mealtime decision-making burden that often drives diabetes...

Description: Shares traded at $22.91 after pricing at $18, valuing the clinical-stage biotech at about $1.2 billion.

Description: It could be another tough year for the once-soaring drugmaker.

Description: ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.

Description: MDT vs. ESLOY: Which Stock Is the Better Value Option?

Description: A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR)— even on days when mealtime boluses were missed. CareLink™ data showed that the studied user population achieved 76.3% TIR on missed bolus days when using SmartGuard™ technology with recommended optimal settings (100 mg/dL glucose target; two-hour active insulin time). The study investigated off-lab

Description: ISRG trades just 4% below its record high after a 32% surge over the past three months, driven by strong procedure growth, rising utilization, and early traction for the da Vinci 5 system.

Description: Medtronic (MDT) is back in focus after William Blair upgraded the stock to Outperform, highlighting new product ramps tied to FDA approval for the Hugo surgical system and national coverage for the Symplicity Spyral RDN device. See our latest analysis for Medtronic. The William Blair upgrade comes as Medtronic’s share price edges higher in the short term, with a 1-day share price return of 3.03% and a 7-day share price return of 3.78%. Its 1-year total shareholder return of 29.55% points to...

Description: CoreWeave initiated, Shopify downgraded: Wall Street's top analyst calls

Description: If you are wondering whether Medtronic's current share price still offers value, this article will walk through what that price might actually imply about the stock. Medtronic recently closed at US$97.36, with returns of 0.7% over the past week, a 3.9% decline over the last 30 days, 1.4% year to date, 25.7% over 1 year, 36.1% over 3 years, and a 3.6% decline over 5 years. Recent coverage of Medtronic has focused on its position as a large medical technology company and its role in the...

Description: Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.

Description: Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on Monday, January 12, 2026.

Description: Employees feel confident in their future, cared for in the present, and supported through life's biggest moments. NORTHAMPTON, MA / ACCESS Newswire / January 5, 2026 / As a global leader in healthcare technology, Medtronic knows that advancing patient ...

Description: LLY, MDT, ISRG, REGN and JNJ are five defensive medical stocks using AI to drive growth, diagnostics and innovation into 2026.

Description: ALLSTON, Mass., January 04, 2026--Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation System (SNS), a wireless, implantable brain-computer interface designed for closed-loop treatment of memory disorders.

Description: Both can be great portfolio anchors.

Description: From pay packages to succession, investors have been keeping a close eye on CEOs in 2025. Harvard University executive education fellow and former Medtronic (MDT) CEO Bill George joins Market Domination to discuss the CEOs he's watching in 2026. To watch more expert insights and analysis on the latest market action, check out more Market Domination.

Description: BSX's $50B cardiovascular business aims to outpace market growth across EP, WATCHMAN, ICTx and more.

Description: We recently compiled a list of the 7 Most Promising Robotics Stocks According to Wall Street Analysts. Medtronic plc stands fifth among the most promising stocks. TheFly reported on December 18 that Truist Securities maintained its Hold recommendation on MDT but lowered its price objective to $107.00 from $110.00. This revision followed an update to […]

Description: Investors seeking reliable dividends will find that this trio of healthcare stocks offers an exciting combination of safety, growth, and income.

Description: Much in the new year depends on the fundamentals, which remain as complicated as ever. Watch these stocks.

Description: Much in the new year depends on the fundamentals, which remain as complicated as ever. Watch these stocks.

Description: These top robotics stocks are compelling for different reasons.

Description: If you are looking for high yields, this drug maker and this device maker are both worth a deep dive today.

Description: Cardinal Health leads Zacks' list of large-cap MedTech stocks as AI adoption, robotics and rising procedure volumes set up continued gains in 2026.

Description: Growth and income investors can buy these five top dividend stocks now, tomorrow, next week, or next year and hold for the long term.

Description: Boston Scientific trades at a premium, but strong momentum in WATCHMAN, EP and MedSurg growth keeps long-term shareholders in the game despite valuation risks.

Description: If you are wondering whether Medtronic at around $98 is still a smart buy or if most of the upside is already priced in, this article will walk through what the market might be missing. The stock is up 22.9% year to date and 25.2% over the last year, even after a recent 2.5% pullback over the past month. This suggests sentiment has improved but is still a bit cautious after a flat 5 year return of -1.2%. That backdrop comes as Medtronic keeps leaning into high growth areas such as robotic...

Description: MDT vs. ESLOY: Which Stock Is the Better Value Option?

Description: Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.

Description: Medtronic plc (NYSE:MDT) is one of the best healthcare AI stocks to buy now. On December 4, Stifel reaffirmed its Hold rating on Medtronic plc (NYSE:MDT), along with a $105 price target. This action came soon after the FDA granted regulatory approval to Medtronic’s HUGO robotic-assisted surgery (RAS) system. Stifel described the HUGO approval as […]

Description: MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

Description: These companies should have no trouble continuing to increase their dividends in 2026.

Description: Medtronic's (NYSE:MDT) stock up by 3.7% over the past three months. However, its weak financial performance indicators...

Description: New research highlights NVIDIA's AI-driven growth, Netflix's ad-tier momentum and Merck's pipeline progress, while microcaps also make the cut.

Description: MiniMed Group, a subsidiary of Medtronic is looking to spin itself off as an independent company via an initial public offering. The company, which makes medical technology for diabetes patients, filed to go public with the Securities and Exchange Commission on Friday. “Our goal is to accelerate the impact we can have as an independent company focused exclusively on helping insulin-dependent people with diabetes experience more predictable control, greater freedom, and better days while achieving strong outcomes.”

Description: The Northridge, California-based company had a net loss of $21 million on revenue of $1.5 billion for the six months ended October 24, compared with a net loss of $23 million on revenue of $1.3 billion in the corresponding period a year earlier, according to its filing Friday with the US Securities and Exchange Commission. The filing positions the company to join a busy slate of possible debuts in the first months of 2026.

Description: Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of newly issued common stock. The separation is expected to be completed through a series of capital markets transactions, with a preferred path of an IPO and subsequent spl

Description: Medtronic Türkiye hosted 110 students from Darüşşafaka at an event organized with the aim of "awakening curiosity and inspiring future careers in healthcare technologies." NORTHAMPTON, MA / ACCESS Newswire / December 19, 2025 / With its ...

Description: SHANGHAI, December 18, 2025--The eighth China International Import Expo (CIIE) has concluded with record results, underscoring its growing global influence and China’s commitment to openness. Over six days, the expo welcomed 922,000 visits—an all-time high and an 8.2% increase from last year. Intended one-year purchase deals reached $83.49 billion, up 4.4% year-on-year. With 4,108 exhibitors from 138 countries and regions in attendance—the broadest participation to date—this turnout highlighted

Description: Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Description: BSX expands globally with R&D, AI-driven manufacturing and Emerging Markets, aiming for $1B+ revenues in China in 2025.

Description: The global blood glucose monitor market is set to expand from USD 16.5 billion in 2025 to USD 25.4 billion by 2030, growing at a CAGR of 9.1%. This growth is fueled by the increasing prevalence of diabetes, a rising geriatric population, and enhanced self-monitoring awareness. Technological advancements in continuous glucose monitoring (CGM), smartphone integration, and AI data analytics have boosted accuracy and patient engagement. The self-monitoring blood glucose systems segment leads in mark

Description: Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index falling 1.6% and

Description: Appointment Enhances PolyPid’s Strategic, Commercial and Transaction Capabilities Ahead of D-PLEX₁₀₀ New Drug Application SubmissionPETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. “Brooke’s appointment marks an exciting and pivotal moment for P

Description: FDA clears the Medtronic Hugo™ robotic-assisted surgery system for urologic procedures. NORTHAMPTON, MA / ACCESS Newswire / December 15, 2025 / James Choate-Deeds and his wife Caryn held hands and braced themselves for the test results. "It's ...

Description: ATO, MDT, PEP, CAT and SPGI stand out as dividend aristocrats for 2026, offering decades of hikes, solid yields and defensive income.

Description: The company is closing out a strong year on a good note.

Description: If you are looking for dividend stocks that you can buy and hold, consider UPS, General Mills, and Medtronic.

Description: Medtronic (MDT) has quietly outperformed the broader healthcare space over the past year, and that steady climb is getting investors to revisit whether this long standing medical device leader still offers reasonable upside. See our latest analysis for Medtronic. Despite a soft patch in the last week, Medtronic’s roughly 24 percent year to date share price return and solid one year total shareholder return near 25 percent point to steady, not euphoric, momentum as investors warm to its...

Description: In early December 2025, Medtronic’s board approved a US$0.71 per-share cash dividend for the third quarter of fiscal 2026, payable on January 16, 2026, and the company secured FDA clearance for its Hugo robotic-assisted surgery system in urologic procedures while launching its MiniMed 780G system with Abbott’s Instinct sensor across the U.S. Together, these developments highlight how Medtronic is pairing a long-running dividend growth record with fresh momentum in robotics and diabetes...

Description: Intuitive Surgical grapples with a GLP-1-driven bariatric slump but leans on strong general surgery gains and rising da Vinci 5 adoption.

Description: BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.

Description: LAGUNA HILLS, Calif., December 11, 2025--Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean Salmon has been appointed to its Board of Directors. Mr. Salmon will also serve on the Company’s Audit Committee and Compensation Committee.

Description: Berlin Heals Holding AG (Zug, Switzerland) is pleased to announce the appointment of Rob ten Hoedt as the new Chairman of the Board of Directors.

Description: Medtronic's fair value estimate has nudged higher to $111.05 from $109.82 as analysts grow more confident that the company can sustain mid single digit plus organic growth. A slightly lower discount rate and largely unchanged revenue growth outlook reflect a market that is increasingly willing to recognize the durability of Medtronic's cash flow narrative, while still acknowledging execution risks. Read on to see how this evolving Wall Street debate may help investors stay informed about...

Description: Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned new diabetes company.

Description: TIFIN today announced that Andrew Dahlinghaus will join as Chief Operating Officer. He brings more than 25 years of leadership across legal, regulatory, and operational disciplines in technology-driven, highly regulated industries. In this role, he will report directly to Founder and CEO Dr. Vinay Nair and will lead TIFIN's next phase of execution across its AI platform.

Description: Intuitive Surgical's golden crossover arrives amid surging procedures and rapid dV5 adoption, raising the stakes for its bullish momentum.

Description: Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization of AVIM Therapy for treatment of uncontrolled hypertension in patients indicated for a pacemaker NEW HOPE, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships,

Description: These companies have terrific records of increasing their dividends.

Description: That is, if you can handle more volatility.

Description: If you are wondering whether Medtronic is still a solid buy at around $101 a share, or if the easy money has already been made, you are in the right place to unpack what the current price really implies. Despite slipping 3.8% over the last week, the stock is still up 12.1% over the past month, 26.4% year to date, and 24.6% over the last year, which has put valuation firmly back in the spotlight. Much of this renewed interest has come as investors refocus on high quality, cash generative...

Description: Medtronic (MDT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Description: MDT vs. ESLOY: Which Stock Is the Better Value Option?

Description: Medtronic gains from the FDA clearance of its Hugo RAS system, expanding U.S. access to robotic-assisted urologic surgery.

Description: The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 48 consecutive years. The dividend is payable on January 16, 2026,

Description: IDXX surges 75.6% YTD as strong CAG Diagnostics momentum and high-demand software solutions fuel growth.

Description: HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.

Description: Intuitive Surgical's strong growth contrasts with tariff-driven margin pressure, raising questions about its ability to hold gross margins near 67%.

Description: STE posts solid AST and Healthcare growth, but currency swings and macro pressures pose rising challenges.

Description: Things are finally looking up for the company.

Description: With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic programs, a company executive said.

Description: Medtronic (NYSE: MDT), a global leader in surgical innovation, today announced the U.S. Food and Drug Administration (FDA) has cleared the Hugo™ robotic-assisted surgery (RAS) system for use in urologic surgical procedures. The Hugo RAS system's clearance brings a versatile robotic-assisted platform to U.S. surgeons and health systems seeking to expand soft-tissue robotic surgery programs and access to minimally invasive care.

Description: Thermo Fisher expands its Bioprocess Design Centers across Asia, boosting biomanufacturing speed, efficiency and regional innovation.

Description: Resmed sees strong mask sales, strategic acquisitions and international expansion despite macro and competitive challenges.

Description: Medtronic begins the U.S. rollout of MiniMed 780G with Abbott's Instinct sensor, advancing diabetes care.

Description: The healthcare robotics market is driven by advancements in AI, demand for precise surgeries, and the aging population. Opportunities lie in tele-robotics and remote care, extending services to underserved areas. Key players include Intuitive Surgical and Medtronic, with applications in surgery and rehabilitation. Healthcare Robotics Market Healthcare Robotics Market Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Healthcare Robotics Market - Global Industry Size, Share, Trends, Opportunity, and

Description: Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed™ systems. Following U.S. FDA clearance of the system earlier this year to enable integration with the Instinct sensor, the system is now shipping to customers across the U.S., marking a major milestone in diabetes technology and delivering a smart, seamless way to mana

Description: Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.

Description: The mHealth market is poised for growth driven by smartphone adoption and rising chronic conditions, promoting remote monitoring and patient-centric care. Challenges include data security concerns. Integrating AI/ML offers personalized health insights. mHealth Market mHealth Market Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "mHealth Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering. The Global mHealth Marke

Description: Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companiesStrong track record of launching breakthrough technologies across spine, neurosurgery and pain managementStrengthens Aclarion’s commercial execution as the Company expands adoption and payer engagement across the Eastern U.S. BROOMFIELD, Colo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a heal

Description: Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.

Description: Shareholders appeared to be happy with Medtronic plc's ( NYSE:MDT ) solid earnings report last week. Looking deeper at...

Description: HSIC gains momentum as Henry Schein One rolls out AI-powered dental workflows unveiled at the Greater New York Dental Meeting.

Description: Medtronic plc (NYSE:MDT) is included among the 15 Best Boring Dividend Stocks to Buy. On November 20, Barclays raised its price targe⁠t on Medtronic plc (NYSE:MDT) to $111 from $109 while maintaining an Overweight rating‌,⁠ following a‍ strong⁠ quarter that exceeded expectations an‌d prompted the fi‌rm to increase its estimates, as reported by The Fly. […]

Description: If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners.

Description: Medtronic plc (NYSE:MDT) ranks among the best slow growth stocks to invest in. Truist Securities increased its price target for Medtronic plc (NYSE:MDT) to $110 from $103 on November 20, while maintaining a Hold rating on the company’s shares. The gain comes after Medtronic’s fiscal second-quarter results, which revealed revenue growth led by the company’s […]

Description: Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.

Description: During the recent China International Import Expo (CIIE), the reporter delivered on-camera coverage to offer an interpretive guide to the event.

Description: Medtronic reported strong second-quarter results and raised its revenue and earnings guidance for the coming quarters and fiscal years, with management highlighting a renewed focus on tuck-in acquisitions in higher-growth cardiology and neuroscience segments. The company’s emphasis on investments in near- or on-market technologies, alongside upward guidance revisions, signals confidence in ongoing innovation and execution across its core businesses. We’ll examine how this improved outlook...

Description: The Middle East & Africa home healthcare market is growing rapidly, driven by rising demand for home-based medical care. Key opportunities include expansion in the services segment, leveraging the market's CAGR of 8.1% from 2019 to 2024, and addressing competitive pressures to capture market share.Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Home Healthcare in Middle East & Africa" report has been added to ResearchAndMarkets.com's offering.Home Healthcare in Middle East & Africa industry profi

Description: Medtronic (MDT) gave investors something to talk about after reporting higher sales and profits compared to last year, and raising its outlook for both revenue and earnings. See our latest analysis for Medtronic. Medtronic’s upbeat outlook has added fuel to a rally that’s been building for much of this year, with the stock’s share price climbing nearly 31% year-to-date and posting a robust 11.6% 1-month gain. Strong quarterly results and plans for strategic acquisitions in high-growth therapy...

Description: Restore Medical Ltd., a privately held medical device company developing a novel transcatheter therapy for heart failure, today announced the appointment of Chris Cleary, former Senior Vice President of Corporate Development at Medtronic, as Chairman of its Board of Directors.

Description: The Pediatric Interventional Cardiology Market is poised for significant growth, projected to rise from USD 2.42 billion in 2024 to USD 4.34 billion by 2033, exhibiting a 6.68% CAGR. This expansion is driven by the increasing prevalence of congenital heart defects such as VSD, PDA, and ASD in children. The advent of advanced medical devices and the shift towards non-invasive treatments also contribute to market growth. The U.S. stands out as a key player due to rising infant cardiac abnormalitie

Description: Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.

Description: Medtronic stock jumped 2% on Monday as it broke out to a 52-week high and is showing signs of strong accumulation. Medtronic stock recently received an RS Rating upgrade from 67 to 82 making it a great stock to consider for a bullish option trade. A bull call spread involves buying a call and then selling a further out-of-the-money call.

Description: A report higher Q4 revenues and lifts its 2026 outlook, yet the stock slips as margins narrow across key business segments.

Description: Medtronic stock has recently seen its fair value price target raised to $109.82 per share, up from $101.13. This change reflects improved analyst sentiment. The upward revision, combined with a slightly lower discount rate, is largely attributed to the company's robust revenue growth projections and continued operational strength. Stay tuned to discover the key drivers behind these changes and how you can keep up with the evolving narrative around Medtronic’s outlook. Analyst Price Targets...

Description: Underscoring India's rising influence in global cardiovascular innovation, Meril Life Sciences presented the one-year outcomes from the pivotal LANDMARK Randomized Controlled Trial (RCT) during the Late-Breaking Trial sessions at PCR London Valves 2025, one of the world's most respected structural heart conferences. This milestone marks a significant moment for Indian MedTech, as the indigenous, balloon-expandable Myval THV series is directly compared with leading international transcatheter val

Description: The global defibrillator market is forecasted to expand significantly, increasing from US$ 13.74 billion in 2024 to US$ 25.80 billion by 2033, with a steady CAGR of 7.25%. Key drivers include the proliferation of public access defibrillators, expanded ambulance services, and a surge in cardiac ailments. Defibrillators like AEDs and manual devices remain crucial in enhancing survival rates during cardiac arrest emergencies. Top players such as Medtronic, Boston Scientific, and Philips are pivotal

Description: The global neonatal intensive care market is forecasted to grow from $3.68 billion in 2024 to $6.27 billion by 2033, at a CAGR of 6.10%. Neonatal Intensive Care (NIC) focuses on critically ill newborns, particularly premature or congenital-condition babies. The rise in medical technology boosts survival rates, increasing NICU demand. Key players like Masimo Corporation, 3M Company, Medtronic PLC, and others are advancing in this life-saving area. Recent innovations, sustainability efforts, and s

Description: The respiratory care devices market is projected to grow from $24.16 billion in 2024 to $49.19 billion by 2033, at a CAGR of 8.22%. The rise is fueled by increasing cases of respiratory diseases such as asthma, COPD, and sleep apnea. Key devices include nebulizers, inhalers, CPAP machines, and ventilators, crucial for therapy and patient monitoring. Top players like Medtronic, Philips, GE Healthcare, and others are driving innovation. Sustainability efforts are notable among companies like Baxte

Description: Intuitive Surgical's robotics surge and Medtronic's broad innovation push set the stage for a high-tech showdown in next-gen minimally invasive care.

Description: SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces the appointment of Farhan Shahab as Vice President of Quality. Mr. Shahab brings over 25 years of experience to BioCardia in similar executive roles. Mr. Shahab joins BioCardia from Welldoc (a digital health company focused on chronic disease management), where he served as Vice P

Description: The global Medical Precision Parts Market is projected to grow at a CAGR of 5.78% from 2024-2030. Driven by lab automation, precision fluidic components like micro-valves and pipetting heads advance personalized medicine. Advanced engineering boosts biocompatibility and anti-fouling, exemplified by Medtronic implants. CNC-machined parts lead with 28% market share, while metals, particularly titanium and stainless steel, drive demand in orthopedic implants. North America dominates due to advanced

Description: Medtronic is proving that it's a reliable company to invest in.

Description: Medtronic is nearing a crowning achievement.

Description: Robotic surgery is a hot field, with new entrants coming.

Description: We recently published 13 Stocks That Crossed Jim Cramer’s Radar. Medtronic plc (NYSE:MDT) is one of the stocks Jim Cramer discussed. Medtronic plc (NYSE:MDT) is a medical technology company that makes and sells devices for cardiovascular, neuroscience, and surgical applications. Cramer has discussed the firm on a handful of occasions in 2025. One such discussion […]

Description: Ever wondered if Medtronic could be a hidden gem in today’s market? Let’s break down what’s really going on with its stock value and what that might mean for potential investors like you. Medtronic’s share price has climbed 3.3% in the last week and is up a notable 23.8% year-to-date, suggesting either confidence in its long-term prospects or changing attitudes around risk in the healthcare sector. News has recently highlighted Medtronic’s focus on innovation, including partnerships and new...

Description: These companies have been raising their payouts for a combined 101 consecutive years.

Description: The global surgical stapling devices market, valued at $5.23 billion in 2023, is anticipated to grow to $8.32 billion by 2029, with a CAGR of approximately 8%. This growth is propelled by the rising demand for minimally invasive procedures and increased healthcare investments, especially in emerging nations. Market segmentation highlights the dominance of disposable and powered surgical stapling devices due to convenience and enhanced functionality. North America leads, driven by innovative tech

Description: Medtronic Spark Scholarship provides financial assistance and access to support services for students pursuing health tech and related degrees NORTHAMPTON, MA / ACCESS Newswire / November 20, 2025 / Medtronic, a global leader in healthcare technology, ...

Description: RBC Capital raised the firm’s price target on Medtronic (MDT) to $118 from $111 and keeps an Outperform rating on the shares. The company delivered a 1.0% beat on sales and 3.8% on EPS in Q2, driven by accelerating cardiovascular performance, the analyst tells investors in a research note. RBC further cites Medtronic expecting similar growth in Q3 and to exit the FY at 6%, noting that its thesis of growth acceleration is playing out. Published first on TheFly – the ultimate source for real-time,

Description: The diabetes care devices market is driven by rising diabetes cases and demand for advanced monitoring and insulin solutions. Opportunities lie in emerging markets where lifestyle shifts increase diabetes rates, along with innovations like AI analytics and connected devices accelerating personalized care.Dublin, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Care Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and For

Description: Medtronic shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 67 to 82.

Description: DoorDash, Baidu upgraded: Wall Street's top analyst calls

Description: Companies in The News Are: MDT,MGIC,AS,ESLT

Description: Pre-Market Stock Futures: Futures are trading higher this morning, as all the major indices once again closed lower on Tuesday, marking the fourth straight day of losses. The Dow Jones Industrials closed down 1.07% at 46,091, while the S&P 500 was last seen at 6617, down 0.83%. The NASDAQ, which has been hit the hardest ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: DoorDash, Freeport-McMoRan, GitLab, Home Depot, Medtronic, Molson-Coors, and More

Description: Intuitive Surgical's Ion platform represents robust growth potential with strong procedure growth. Clinical trial data demonstrate superiority in diagnostic yield.

Description: Medtronic achieved global revenue of almost $9bn in Q2 FY26, with its cardiovascular portfolio contributing $3.44bn.

Description: Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.

Description: December Nasdaq 100 E-Mini futures (NQZ25) are trending up +0.44% this morning, signaling a modest rebound from a bruising stretch of losses, while investors look ahead to an earnings report from AI darling Nvidia.

Description: ↘️ Home Depot (HD): The big-box retailer cut its annual outlook as the home-improvement downturn continues. The stock closed down more than 6%, its biggest daily decline since 2023. Shares were up slightly after hours.

Description: Nvidia and Microsoft unveil a massive AI partnership with Anthropic, Home Depot reduces its full-year sales outlook, and Cloudflare reports widespread outages.

Description: Wall Street's major equity benchmarks on Tuesday slumped to their lowest levels since October as maj

Description: US equity indexes closed lower Tuesday as consumer discretionary and technology sectors slumped.

Description: A home improvement retailer faced pressure on Tuesday, Nov. 18, 2025, as housing market headwinds weighed on earnings, while a medical device maker benefitted from strong demand.

Description: Medtronic stock jumped and broke out Tuesday on a "clean beat" driven mainly by its pulsed field ablation technology.

Description: Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Heal

Description: US benchmark equity indexes were lower intraday, weighed down by technology giants Microsoft (MSFT)

Description: Medtronic PLC (MDT) surpasses expectations with robust growth in cardiac ablation and raises full-year guidance, despite challenges in the cryo business and tariffs.

Description: US equity indexes declined in midday trading on Tuesday, but were off their respective session lows.

Description: Julie Hyman kicks off Yahoo Finance's Market Minute, taking a look at three of the trending stories on Wall Street, including Alphabet's (GOOG, GOOGL) new Gemini 3 AI model, Klarna's (KLAR) first earnings release since going public, and Medtronic's (MDT) earnings beat. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Description: Major U.S. equities indexes extended their slide Tuesday afternoon, amid worries about an AI bubble.

Description: Medtronic shares took off after the company posted better financial results than expected, boosted by what management called a “robust” volume of medical procedures. Medtronic sells surgical tools, plus medical devices that treat heart conditions, diabetes, and a range of other conditions, so it benefits when hospitals do more medical procedures. Investors have closely tracked volumes at Medtronic and its peers since the pandemic, which led to delays in many nonessential surgeries.

Description: Medtronic (MDT) raised its full-year outlook on Tuesday as the medical device maker logged stronger-

Description: MDT posts Q2 earnings and revenue beat, powered by strong Cardiovascular growth and a raised 2026 outlook that lifts its shares.

Description: The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Description: US equity futures were down ahead of Tuesday's opening bell as traders turned their focus to Nvidia'

Description: October brings 'tentative reprieve' to price corrections

Description: Medtronic (MDT) delivered earnings and revenue surprises of +3.82% and +1.11%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Medtronic raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.

Description: Market Domination Overtime host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, November 18, including quarterly earnings results from companies like Home Depot (HD), Baidu (BIDU, 9888.HK), and Klarna (KLAR); the latest Homebuilder Confidence Index reading; and commentary from Federal Reserve governor Michael Barr. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.

Description: New analyst reports spotlight Oracle's cloud momentum, strategic partnerships and expected fiscal 2026 sales growth.

Description: Consider buying Medtronic for its dividend and Pfizer for its turnaround potential if you are looking for attractive healthcare investments in November.

Description: It’s a big week for earnings this week with Nvidia and some key retail names taking center stage. This week we have Nvidia, Home Depot, Walmart, Target, Lowes, Palo Alto Networks, Medtronic and Pdd Holdings all reporting.

Description: Top market opportunities in the IoMT sector include the rapid growth of wearable devices, real-time monitoring, and the patient end-user segment. Fastest growth is expected in the Asia Pacific and South America regions. Companies should focus on non-invasive monitoring solutions, strategic partnerships, and educating end-users to capitalize on these trends. Global Internet Of Medical Things (IoMT) Market Global Internet Of Medical Things (IoMT) Market Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Th

Description: Investors can look forward to the restart of official economic data, starting with the September jobs report. A heavy dose of earnings is on the way too, including results from Nvidia, Home Depot and Walmart.

Description: Stocks face potentially a volatile week. Not just from the earnings that are due from the likes of Nvidia, Walmart, Home Depot, Lowe's and Target. There's also a bit of unease settling over markets coming from crypto land, where prices for bitcoin, ethereum and other crypto currencies have slumped ...

Description: The final full week of trading in November will bring investors key results from the biggest AI and retail names in the market.

Description: I'm a big fan of reliable dividend payers, and a few of the most reliable ones are attractively priced right now.

Description: Market Domination Overtime host Myles Udland previews several of the biggest stories to come throughout next week, including quarterly earnings results from major companies like Nvidia (NVDA), Home Depot (HD), Target (TGT), and Walmart (WMT); the latest round of commentary from top Federal Reserve officials alongside the minutes from the central bank's October FOMC meeting; and the release of the long-awaited September jobs report scheduled for Thursday, November 20. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.

Description: With the government shutdown over, investors can look forward to the restart of jobs and inflation data, starting with the September jobs report. In the meantime, a heavy dose of earnings are on the way, including results from AI giant Nvidia and retailers Home Depot and Walmart.

Description: On November 12, 2025, Minze Health announced a three-year agreement with Medtronic to commercialize the Minze Diary Pod across the EMEA region for patients with overactive bladder symptoms using Medtronic’s InterStim system. This collaboration adds a digital health solution to Medtronic’s SNM therapy pathway, aiming to improve patient data collection and clinical decision-making in urinary care. We’ll examine how integrating an automated bladder diary could influence Medtronic’s positioning...

Description: The Oncology Institute (TOI) delivered earnings and revenue surprises of -16.67% and +11.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2025.

Description: OnPoint Surgical, Inc., a leader in Augmented Reality (AR) and Artificial Intelligence (AI) guidance for spinal interventions, today announced the appointment of Jeremy Laynor as Chief Commercial Officer (CCO).

Description: Medtronic's Q2 results may see a lift from solid Cardiovascular momentum and strong Diabetes segment growth.

Description: J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.

Description: ANTWERP, Belgium, November 12, 2025--Minze Health partners with Medtronic to integrate its automated bladder diary, Minze Diary Pod, into Sacral Neuromodulation care for OAB patients.

Description: Medtronic (MDT) shares edged slightly higher this week, with the stock gaining about 0.5% in the last trading session. Investors seem to be keeping an eye on the company’s performance as broader healthcare trends unfold. See our latest analysis for Medtronic. Medtronic’s 15.5% share price return so far this year reflects cautious optimism around its progress, even as recent 30-day softness has tempered momentum. The company’s one-year total shareholder return of 8.4% highlights steady but...

Description: Medtronic has its own surgical robot and it is working to become a more profitable business.

Description: The Diabetic Foot Ulcer Treatment Market offers growth opportunities due to rising diabetes prevalence, demand for cost-effective, painless treatments, and increased focus on advanced wound care and telemedicine. The expanding elderly population and obesity rates further drive market demand, while digital health solutions enhance access and outcomes. Diabetic Foot Ulcer Treatment Market Diabetic Foot Ulcer Treatment Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Diabetic Foot Ulcer Treatm

Description: The regenerative medicine market offers significant opportunities in personalized stem cell therapies, driven by rising cancer cases and demand for effective chronic disease treatments. Emerging economies show potential for growth, propelled by an increasing need for tissue engineering and organ transplantation solutions. Regenerative Medicine Market Regenerative Medicine Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market - Global Industry Size, Share, Trends, Opp

Description: Together, we can make a positive impact on the environment through advocacy, education, and connection NORTHAMPTON, MA / ACCESS Newswire / November 11, 2025 / We're focused on building a more sustainable future. To help with this, a grassroots group ...

Description: The board of directors of TE Connectivity plc (NYSE: TEL), a world leader in connectors and sensors, has appointed Ken Washington to the board, effective November 17, 2025.

Description: Quanterix (QTRX) delivered earnings and revenue surprises of -56.52% and +4.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Secured $147.6 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by $71.6 million in committed capital from Medtronic and Ligand, as well as $30 million from TerumoInitiated patient enrollments in the Virtue Trial evaluating Virtue® Sirolimus AngioInfusion™ Balloon (“Virtue SAB”) trial versus commercially available paclitaxel-coated balloon Demonstrated partnership-driven business model execution with

Description: Medtronic stock has seen its price target updated, with key financial assumptions reflecting both the company’s stable outlook and a slightly higher perception of risk. Improving analyst sentiment has supported this shift, as optimism grows around Medtronic’s product pipeline and strategic priorities. However, some experts remain watchful of potential near-term volatility. Read on to discover how you can stay informed about these evolving perspectives and what they might mean for the stock’s...

Description: The Sports Medicine industry is projected to grow significantly, reaching US$ 12.32 Billion by 2033 from US$ 7.27 Billion in 2024, marking a CAGR of 6.04%. This growth is driven by increased sports participation, a focus on injury prevention, and advancements in sports medicine technology like minimally invasive surgical tools. Companies such as Temple Ortho Biologics are pioneering solutions for young athletes. Leading market players include Zimmer Biomet, Medtronic, and Stryker, emphasizing in

Description: Intuitive Surgical's shares soar over 28% in a month on da Vinci 5 momentum, but margin and valuation pressures suggest caution for new buyers.

Description: Medtronic (MDT) closed the most recent trading day at $92.2, moving +2.38% from the previous trading session.

Description: "Driven by Technological Advances and Expanding Clinical Applications, Patient Monitoring Devices Are Revolutionizing Healthcare Delivery Across Hospitals, Home Care, and Remote Settings"Boston, Nov. 07, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Patient Monitoring Devices: Global Markets” is projected to grow from $36.7 billion in 2025 to $55.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.7% during the forecast period of 2025 to 2030.

Description: Key Insights The projected fair value for Medtronic is US$99.25 based on 2 Stage Free Cash Flow to Equity Current share...

Description: The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

Description: Technological advancements, such as AI integration, enhance diagnostics and patient compliance, are propelling market expansion. Despite challenges like high screening costs and limited reimbursement policies, increasing awareness of early detection supports market growth. Colon Screening Market Colon Screening Market Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Colon Screening Market Size and Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering.The

Description: The cardiovascular repair and reconstruction devices market offers vast opportunities with advancements in minimally invasive techniques, bioengineered materials, and personalized, patient-centered approaches. Growth is fueled by innovations in heart valve technology, rising healthcare expenditure, and an aging population seeking advanced treatment options. Cardiovascular Repair and Reconstruction Devices Market Cardiovascular Repair and Reconstruction Devices Market Dublin, Nov. 06, 2025 (GLOBE

Description: Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, November 18, 2025, for its second quarter of fiscal year 2026, which ended on Friday, October 24, 2025.

Description: Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +14.29% and +1.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: BSX's Q3 EP sales soar 63% on FARAPULSE momentum, FDA label expansion and rising global adoption.

Description: The general manager for the business says building a market is something the medtech giant knows how to do.

Description: The global disposable medical device market is set to expand from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, driven by a 4.9% CAGR. Factors such as heightened concern over hospital-acquired infections (HAIs), increased surgical procedures, and demand for cost-effective, single-use solutions propel growth. The drug delivery devices segment is leading in growth due to rising chronic disease cases and vaccine programs. The plastic-based segment is growing due to cost-effectiveness an

Description: Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.

Description: Healthcare has been an extraordinarily resilient industry to put cash to work in through the years.

Description: Cardiac mapper turned treatment of his own heart condition into a new career NORTHAMPTON, MA / ACCESS Newswire / November 3, 2025 / David Stalls thought the dangerous heart rhythm problem that plagued his health was a curse-until he turned treating ...

Description: NEW HOPE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced that company management will host a business update call on Wednesday, November 12th at 8:00 AM ET. The business update will focus on recent significant clinical, strategic and financing develop

Description: The US neurology devices market is driven by rising neurological disorders and tech advancements, supported by government R&D funding. Key segments include neurostimulation and neurosurgery devices, with major players like Medtronic and Boston Scientific. Opportunities lie in innovation and strategic collaborations. U.S. Neurology Devices Market U.S. Neurology Devices Market Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Neurology Devices Market Size, Share, Growth, Trends, Opportu

Description: With its stock down 4.5% over the past month, it is easy to disregard Medtronic (NYSE:MDT). To decide if this trend...

Description: The AI rally has many investors wondering where to turn in anticipation of its end. The medical-device maker is one solid option.

Description: In the most recent trading session, Medtronic (MDT) closed at $91.73, indicating a -1.61% shift from the previous trading day.

Description: NORTHAMPTON, MA / ACCESS Newswire / October 29, 2025 / Medtronic Decision means millions of Americans have access to the Medtronic Symplicity Spyral™ renal denervation system Edwin Jimenez knows a thing or two about staying physically fit. "I grew ...

Description: National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.

Description: Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has released the final National Coverage Determination (NCD) on renal denervation, applicable to the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity blood pressure procedure. This final determination will now provide Medicare patients with access to the Symplicity blood pressure procedure for the treatment of uncontrolled hyp

Description: The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a CAGR of 5.84% from 2025-2033. This growth is driven by the rising diabetes prevalence, technological innovations in insulin delivery, and increased awareness of continuous glucose monitoring and personalized diabetes care. Key players like Medtronic, Insulet, and Tandem Diabetes Care are leading the market with smart insulin pumps integrated with CGMs for automated and rem

Description: Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

Description: Medtronic is expected to release its second-quarter results next month, and analysts project a single-digit earnings increase.

Description: The long-awaited face-off between these two medical device giants is finally upon us.

Description: The cardiovascular repair market is fueled by an aging population, technological advancements, and the rise in comorbidities. Opportunities lie in innovative, minimally invasive devices, value-based contracting, and regional market dynamics. Emphasizing personalized, data-driven solutions and supply chain resilience is crucial for growth. Cardiovascular Repair & Reconstruction Devices Market Cardiovascular Repair & Reconstruction Devices Market Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "Card

Description: These two healthcare giants are doing what they need to do to get their businesses rocking and rolling again.

Description: Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new, long-term results from its final report of the SPYRAL HTN-ON MED randomized clinical trial, showing that patients treated with the Symplicity™ Spyral renal denervation (RDN) procedure experienced significantly greater reductions in blood pressure compared to sham patients through three years. The data were presented as part of Featured Clinical Research during the 2025 Transcatheter Cardiovascular Therapeut

Description: One is an out-of-favor dividend stock that's working to return to growth, and one just scored a big win.

Description: Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).

Description: Medtronic’s stock narrative has recently shifted, as reflected in a modest rise in the consensus analyst price target from $99.90 to $101.13. This adjustment follows updated models from analysts who have responded to increasing investor optimism and anticipation surrounding key product launches. Stay tuned to discover how investors and observers can keep pace with these ongoing updates to Medtronic’s evolving outlook. What Wall Street Has Been Saying Analyst sentiment toward Medtronic has...

Description: In the closing of the recent trading day, Medtronic (MDT) stood at $94.21, denoting a -1.76% move from the preceding trading day.

Description: The GCC catheter market is projected to grow from USD 579.83 million in 2024 to USD 1.28 billion by 2033, with a CAGR of 9.21% from 2025 to 2033. This growth is driven by an increase in chronic diseases, surgical procedures, and advanced healthcare infrastructure across GCC countries. The demand for minimally invasive treatments and the aging population further bolster market expansion. Key sectors such as cardiovascular, microcatheters, and intermittent catheters are witnessing significant grow

Description: The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.

Description: Solventum (NYSE: SOLV) announced today the appointment of Heather Knight as Chief Commercial Officer, effective November 10, 2025. In this newly created role, Ms. Knight will oversee global commercial and R&D operations across Solventum's MedSurg, Dental Solutions and Health Information Systems segments, and will report directly to CEO Bryan Hanson.

Description: CALGARY, Alberta, Oct. 21, 2025 (GLOBE NEWSWIRE) -- A growing number of companies are using Giftbit, a simple but powerful digital rewards platform, to achieve remarkable results. Gift cards and prepaid cards, sent instantly and at scale, are effective in countless business scenarios. Three companies to watch, MustardHub, Medtronic, and Natural Factors, are seeing success with simplified incentive programs that increase engagement, and deliver consistent experiences across the globe. Customer Sp

Description: Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Medtronic PLC (MDT) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. This detailed report serves as a valuable source of data, analysis, and actionable insights into Medtronic's portfolio of pipeline products. It provides essential information about the company, its key products, and esteemed brands, enhancing decision-making capabilities and assisting in creating effective counter strategies to secure a

Description: MINNEAPOLIS, MN / ACCESS Newswire / October 21, 2025 / MD&M Midwest, the region's largest annual end-to-end design and manufacturing event taking place on October 21-22 at the Minneapolis Convention Center announces keynote speakers for the event's ...

Description: Key opportunities in the global patient monitoring devices market include expanding use of miniaturized multi-sensing devices and adoption due to stringent regulations, enhanced self-management of chronic diseases, and growth potential in emerging regions. Sustainability and ESG practices also offer competitive advantages. Patient Monitoring Devices Market Patient Monitoring Devices Market Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "Patient Monitoring Devices: Global Markets" report has been

Description: Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.